Skip to main content

Table 3 HCMV seropositive rates and anti-HCMV IgG titre by transplant organs in solid organ transplant recipients

From: Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea

Age (years)KidneyLiverLungHeartp-value
(n = 1436)(n = 579)(n = 69)(n = 100)
≤ 40
Seropositive478 (95.2)57 (98.3)15 (100)34 (94.4)0.716
Titre (aU/mL)57.7 ± 36.665.3 ± 42.669.5 ± 44.451.1 ± 27.00.184
41–60
Seropositive801 (100)400 (99.8)33 (100)47 (97.9)0.073
Titre (aU/mL)60.7 ± 34.6*†81.3 ± 55.5*88.5 ± 72.366.4 ± 60.70.001
≥ 61
Seropositive133 (100)120 (100)21 (100)16 (100)
Titre (aU/mL)59.9 ± 44.2*82.9 ± 56.3*90.3 ± 80.548.8 ± 27.40.001
Total
Age, year44.9 ± 12.4*†52.3 ± 12.0*‡50.2 ± 13.0†§44.3 ± 17.3‡§<0.001
Seropositive1412 (98.3)577 (99.7)a69 (100.0)a97 (97.0)0.024
Titre (aU/mL)59.4 ± 36.1*†80.1 ± 54.5*‡84.3 ± 68.3†§58.1 ± 46.9‡§<0.001
  1. Data are expressed as number (percent) or mean ± standard deviation. *†‡§p-value <0.05 between two groups in post-hoc tests by Bonferroni correction after ANOVA. aadjusted p < 0.05 between two groups using post-hoc analyses based on adjusted standardised residuals. Abbreviation: aU, arbitrary unit